Filing Flows › Siga Technologies (SIGA) › Recalls, complaints & regulation
Siga Technologies (SIGA): clinical trials
Siga Technologies (SIGA) beyond its filings: 1 active clinical trial.
Siga Technologies' latest quarter
Siga Technologies, Q2 2026: revenue $41.0M (-50% year over year), operating margin 33.9%, net earnings $12.5M, operating cash flow $15.2M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Siga Technologies have?
1 active study on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.